x
Filter:
Filters applied
- Oncology
- Abel, E JasonRemove Abel, E Jason filter
- Ziemlewicz, Timothy JRemove Ziemlewicz, Timothy J filter
Publication Date
Please choose a date range between 2016 and 2019.
Author
- Best, Sara L2
- Hinshaw, J Louis2
- Lee, Fred T Jr2
- Lubner, Meghan G2
- Nakada, Stephen Y2
- Wells, Shane A2
- Blute, Michael L Jr1
- Downs, Tracy M1
- Dreyfuss, Leo D1
- Grimes, Matthew1
- Hedican, Sean P1
- Huang, Wei1
- Jarrard, David F1
- Kyriakopoulos, Christos1
- Lang, Joshua M1
- Mankowski Gettle, Lori1
- Mann, Michael A1
- Miller, Brady L1
- Shi, Fangfang1
- van Roo, Jason R1
Oncology
3 Results
- Oncology
Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma
UrologyVol. 134p148–153Published online: August 26, 2019- Leo D. Dreyfuss
- Shane A. Wells
- Sara L. Best
- Sean P. Hedican
- Timothy J. Ziemlewicz
- Meghan G. Lubner
- and others
Cited in Scopus: 6To analyze risk factors and patterns of RCC recurrence following percutaneous ablation for stage 1 tumors and develop risk-stratified follow-up imaging protocols. - Oncology
Comparative Analysis of Surgery, Thermal Ablation, and Active Surveillance for Renal Oncocytic Neoplasms
UrologyVol. 112p92–97Published online: October 10, 2017- Brady L. Miller
- Lori Mankowski Gettle
- Jason R. Van Roo
- Timothy J. Ziemlewicz
- Sara L. Best
- Shane A. Wells
- and others
Cited in Scopus: 15To compare oncological and procedural outcomes for renal oncocytic tumors treated with surgery, thermal ablation, or active surveillance. - Oncology
Metastatic Tumor Burden Does Not Predict Overall Survival Following Cytoreductive Nephrectomy for Renal Cell Carcinoma: a Novel 3-Dimensional Volumetric Analysis
UrologyVol. 100p139–144Published online: September 22, 2016- Michael L. Blute Jr
- Timothy J. Ziemlewicz
- Joshua M. Lang
- Christos Kyriakopoulos
- David F. Jarrard
- Tracy M. Downs
- and others
Cited in Scopus: 4To compare 1-dimensional (1D) and 3-dimensional (3D) volume measurements and determine whether primary tumor (PT) burden is predictive of overall survival (OS) following cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC).